Koyfin Home > Directory > Health Care > Ironwood Pharmaceuti > EBITDA / Interest Expenses

Ironwood Pharmaceuti EBITDA / Interest Expenses Chart (IRWD)

Ironwood Pharmaceuti annual/quarterly EBITDA / Interest Expenses from 2010 to 2020. EBITDA / Interest is the interest coverage ratio and measures the ability of a company to service its debt.
  • Ironwood Pharmaceuti EBITDA / Interest Expenses for the quarter ending June 06, 2020 was $5m a -55.20% decrease of -3m year over year
  • Ironwood Pharmaceuti EBITDA / Interest Expenses for the last 12 months ending June 06, 2020 was $6m a 39.36% increase of 2m year over year
  • Ironwood Pharmaceuti Annual EBITDA / Interest Expenses for 2019 was $4m a 100.68% increase of 4m from 2018
  • Ironwood Pharmaceuti Annual EBITDA / Interest Expenses for 2018 was $0m a -3,215.70% increase of 1m from 2017
  • Ironwood Pharmaceuti Annual EBITDA / Interest Expenses for 2017 was $-1m a 13.67% decrease of 0m from 2016
Other Ratios Metrics:
  • Ironwood Pharmaceuti Total Debt / Capital for the quarter ending September 09, 2018 was $193m a 49.45% increase of 95m year over year
  • Ironwood Pharmaceuti Other Liabilities for the quarter ending December 12, 2018 was $43m a -224.96% decrease of -96m year over year
  • Ironwood Pharmaceuti Total Debt / Equity for the quarter ending December 12, 2017 was $4,063m a 86.25% increase of 3,505m year over year
View Chart On Koyfin

Quarterly IRWD EBITDA / Interest Expenses Data

06/2020$5m
03/2020$2m
12/2019$8m
09/2019$7m
06/2019$3m
03/2019$-1m
12/2018$3m
09/2018$-2m
06/2018$-1m
03/2018$-3m

Annual IRWD EBITDA / Interest Expenses Data

2019$4m
2018$0m
2017$-1m
2016$-1m
2015$-3m
2014$-7m
2013$-11m
2012$-1,041m
2011$-891m
2010$-279m